Literature DB >> 21569127

Single-center experience with third and fourth kidney transplants.

Katrin Kienzl-Wagner1, Walter Mark, Manuel Maglione, Gerald Brandacher, Robert Öllinger, Raimund Margreiter, Johann Pratschke, Claudia Bösmüller.   

Abstract

Kidney retransplantation is often associated with a higher immunological risk than is primary renal transplantation. Faced with increasing organ shortage and growing waiting lists, results of kidney retransplantation are of particular interest. Fifty-six third and fourth kidney transplants were analyzed retrospectively. Parameters included patient and donor demographics, operative details, incidence of surgical, immunological and infectious complications and patient and graft survival. Patients receiving third kidney grafts had 1- and 5-year patient/graft survival rates of 97.4%/72.9% and 88.9%/53.6%, respectively. Episodes of acute rejection and delayed graft function were observed in 44% and 49% of these patients. Fourth kidney transplantation was associated with 1- and 2-year patient/graft survival rates of 84.8%/68.5% and 63.6%/47%, respectively. Acute rejection and delayed graft function occurred in 33% and in 60% of cases. Acceptable patient and graft survival may be achieved after third and fourth kidney transplantation. Graft losses in this sensitized population are mainly because of rejection. Profound immunosuppression may lead to major infectious problems.
© 2011 The Authors. Transplant International © 2011 European Society for Organ Transplantation.

Entities:  

Mesh:

Year:  2011        PMID: 21569127     DOI: 10.1111/j.1432-2277.2011.01269.x

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  8 in total

1.  Graft and patient survival outcomes of a third kidney transplant.

Authors:  Robert R Redfield; Meera Gupta; Eduardo Rodriguez; Alexander Wood; Peter L Abt; Matthew H Levine
Journal:  Transplantation       Date:  2015-02       Impact factor: 4.939

2.  Immunologic and non-immunologic complications of a third kidney transplantation.

Authors:  Hyun Seon Kim; Jae Young Kim; Eun Jin Kang; Yoon Seok Choi; Ji-Il Kim; In Sung Moon; Bum Soon Choi; Cheol Whee Park; Chul Woo Yang; Yong-Soo Kim; Byung Ha Chung
Journal:  Korean J Intern Med       Date:  2015-08-27       Impact factor: 2.884

3.  Risk-adjusted analysis of relevant outcome drivers for patients after more than two kidney transplants.

Authors:  Lampros Kousoulas; Florian W R Vondran; Paulina Syryca; Juergen Klempnauer; Harald Schrem; Frank Lehner
Journal:  J Transplant       Date:  2015-02-01

4.  Patterns of Early Rejection in Renal Retransplantation: A Single-Center Experience.

Authors:  Lan Zhu; Cheng Fu; Kailin Lin; Zhiqiang Wang; Hui Guo; Song Chen; Zhengbin Lin; Zhishui Chen; Gang Chen
Journal:  J Immunol Res       Date:  2016-12-08       Impact factor: 4.818

5.  Surgical Safety and Efficacy of Third Kidney Transplantation in the Ipsilateral Iliac Fossa.

Authors:  Piotr Domagala; Tamar van den Berg; Khe Tran; Turkan Terkivatan; Hendrikus Kimenai; Hermien Hartog; Dennis A Hesselink; Stephan J L Bakker; Jan N Ijzermans; Robert A Pol; Robert C Minnee
Journal:  Ann Transplant       Date:  2019-03-08       Impact factor: 1.530

6.  Long-term outcome of third, fourth and fifth kidney transplantation: technical aspects and immunological challenges.

Authors:  Tamas Benkö; Patrizia Halfmann; Anja Gäckler; Sonia Radünz; Jürgen W Treckmann; Gernot M Kaiser; Dieter P Hoyer
Journal:  Clin Kidney J       Date:  2019-02-25

7.  Outcomes of first versus third kidney transplantations: propensity score matching and paired subgroup analysis-a single-centre experience.

Authors:  Gábor Telkes; László Piros; József Szabó; Gergely Huszty; Katalin Eitler; László Kóbori
Journal:  Langenbecks Arch Surg       Date:  2021-01-17       Impact factor: 3.445

8.  Comparing outcomes of third and fourth kidney transplantation in older and younger patients.

Authors:  Shaifali Sandal; JiYoon B Ahn; Dorry L Segev; Marcelo Cantarovich; Mara A McAdams-DeMarco
Journal:  Am J Transplant       Date:  2021-08-23       Impact factor: 8.086

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.